Eribulin shows early promise in pediatric sarcoma treatment
The drug eribulin, currently approved for the third-line treatment of breast cancer, may represent a new treatment option for pediatric patients with a type of cancer called sarcoma, according to results of preclinical studies ...
Nov 5, 2013
0
0